Aytu Biopharma Inc (AYTU)
1.1800 x 2 1.3800 x 10
Post-market by (Cboe BZX)
1.2400 -0.0100 (-0.80%) 03/21/25 [NASDAQ]
1.1800 x 2 1.3800 x 10
Post-market 1.2400 unch (unch) 16:00 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
Sales | 81,002 | 107,399 | 96,669 | 65,632 | 27,632 |
Cost of Goods | 26,416 | 40,767 | 44,386 | 36,432 | 8,281 |
Gross Profit | 54,586 | 66,632 | 52,283 | 29,200 | 19,351 |
Operating Expenses | 60,256 | 84,464 | 162,575 | 88,502 | 40,763 |
Operating Income | -5,254 | -17,065 | -109,906 | -58,870 | -21,131 |
Interest Expense | 4,792 | 4,963 | 0 | 0 | 0 |
Other Income | -4,030 | 4,977 | 1,017 | 840 | 7,510 |
Pre-tax Income | -14,076 | -17,051 | -108,889 | -58,030 | -13,621 |
Income Tax | 1,768 | 0 | -110 | 259 | 0 |
Net Income Continuous | -15,844 | -17,051 | -108,779 | -58,289 | -13,621 |
Net Income | $-15,844 | $-17,051 | $-108,779 | $-58,289 | $-13,621 |
EPS Basic Total Ops | -2.86 | -5.11 | -74.01 | -69.60 | -60.20 |
EPS Basic Continuous Ops | -2.86 | -5.11 | -74.00 | -69.61 | -60.28 |
EPS Diluted Total Ops | -2.86 | -5.11 | -74.01 | -69.60 | -60.20 |
EPS Diluted Continuous Ops | -2.86 | -5.11 | -74.00 | -69.61 | -60.28 |
EPS Diluted Before Non-Recurring Items | -2.86 | -3.52 | -34.40 | -47.20 | N/A |
EBITDA(a) | $3,615 | $-7,691 | $-24,428 | $-36,888 | $-14,885 |